- Report
- October 2024
- 195 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- April 2025
- 50 Pages
Global
From €2534EUR$2,650USD£2,121GBP
Fluindione is a hematological drug used to treat and prevent thromboembolic disorders, such as deep vein thrombosis and pulmonary embolism. It is a vitamin K antagonist, meaning it works by blocking the action of vitamin K in the body, which is necessary for the formation of blood clots. Fluindione is available in both oral and injectable forms, and is often used in combination with other anticoagulants. It is also used to treat atrial fibrillation, a type of irregular heartbeat.
The Fluindione market is highly competitive, with a number of major pharmaceutical companies offering their own versions of the drug. These include Bayer, Pfizer, Sanofi, and Bristol-Myers Squibb. Generic versions of the drug are also available, produced by a variety of generic drug manufacturers. Show Less Read more